The Upside of Downside Protection (Hegde Nordic)
Stockholm (HedgeNordic) – One of the most widely recognized pearls of wisdom of Warren Buffett goes along the lines of “Rule number one: Don’t lose money. Rule number two: don’t forget rule number one.” A three-member team out of Stockholm comprised of Thomas Pohjanen (pictured), Björn Suurwee and Marek Ozana too believe that avoiding a loss should be the primary goal of their fixed-income macro hedge fund Excalibur.
Energy Hedge Fund Westbeck Eyes “Spectacular” Oil Market Rebound Following Covid Vaccine Breakthrough (Hedge Week)
London-based energy hedge fund Westbeck Capital’s high-flying flagship strategy was brought back down to earth during a dismal October – but the oil-focused fund is staging a November fightback following news of a Covid-19 vaccine breakthrough. The Westbeck Energy Opportunity Fund slipped 10.8 per cent last month – its second double-digit loss in as many months, having suffered a 15 per cent slide in September – after most oil equities were hammered in October.
Thursday 11/19 Insider Buying Report: UEPS, ATRC (Nasdaq.com)
On Tuesday, Net 1 UEPS Technologies’ , Antony C. Ball, made a $624,686 buy of UEPS, purchasing 185,148 shares at a cost of $3.37 a piece. So far Ball is in the green, up about 1.1% on their buy based on today’s trading high of $3.41. Net 1 UEPS Technologies is trading up about 1.8% on the day Thursday. Before this latest buy, Ball bought UEPS at 2 other times during the past year, for a total cost of $902,468 at an average of $3.15 per share. And at AtriCure, there was insider buying on Tuesday, by Director Scott William Drake who bought 12,350 shares at a cost of $40.54 each, for a total investment of $500,669. This purchase marks the first one filed by Drake in the past year. AtriCure is trading up about 6.1% on the day Thursday. Drake was up about 8.0% on the purchase at the high point of today’s trading session, with ATRC trading as high as $43.79 at last check today.
Shockwave Medical Inc (SWAV) President & CEO Douglas Evan Godshall Sold $26.5 million of Shares (Guru Focus)
President & CEO of Shockwave Medical Inc, Douglas Evan Godshall, sold 280,000 shares of SWAV on 11/18/2020 at an average price of $94.56 a share. The total sale was $26.5 million. ShockWave Medical Inc has a market cap of $3.31 billion; its shares were traded at around $96.50 with and P/S ratio of 52.08. GuruFocus has detected 1 severe warning sign with ShockWave Medical Inc.
A Director at Maxlinear (NYSE: MXL) is Selling Shares (Analyst Ratings)
Yesterday, a Director at Maxlinear (MXL), Donald Schrock, sold shares of MXL for $292.3K. Following Donald Schrock’s last MXL Sell transaction on February 13, 2020, the stock climbed by 8.8%. Based on Maxlinear’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $157 million and GAAP net loss of -$36,645,000. In comparison, last year the company earned revenue of $80.02 million and had a GAAP net loss of $4.71 million. The company has a one-year high of $30.52 and a one-year low of $7.79. Currently, Maxlinear has an average volume of 405.58K.
Square Inc (SQ) President, CEO & Chairman Jack Dorsey Sold $17.6 million of Shares (Guru Focus)
President, CEO & Chairman of Square Inc, Jack Dorsey, sold 100,000 shares of SQ on 11/16/2020 at an average price of $175.95 a share. The total sale was $17.6 million. Square Inc is a software company offering solutions ranging from payments and point-of-sale services to financial and marketing services. It offers a free software app with its hardware to turn mobile devices into powerful POS solutions in minutes.
